NO982935L - Hyaluronsyre reseptor bindemiddel og anvendelse derav - Google Patents

Hyaluronsyre reseptor bindemiddel og anvendelse derav

Info

Publication number: NO982935L
Authority: NO; Norway
Prior art keywords: cac; arg; binder; letter code; code
Prior art date: 1995-12-27

Application number

NO982935A

Other languages

English (en)

Norwegian (no)

Other versions

NO982935D0 (no

Inventor

Eva Turley

Original Assignee

Hyal Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-27

Filing date

1998-06-24

Publication date

1998-08-27

1998-06-24 Application filed by Hyal Pharma Corp filed Critical Hyal Pharma Corp

1998-06-24 Publication of NO982935D0 publication Critical patent/NO982935D0/no

1998-08-27 Publication of NO982935L publication Critical patent/NO982935L/no

Links

239000011230 binding agent Substances 0.000 title abstract 4
101001054921 Homo sapiens Lymphatic vessel endothelial hyaluronic acid receptor 1 Proteins 0.000 title 1
102100026849 Lymphatic vessel endothelial hyaluronic acid receptor 1 Human genes 0.000 title 1
150000001413 amino acids Chemical class 0.000 abstract 4
239000003814 drug Substances 0.000 abstract 4
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
229940079593 drug Drugs 0.000 abstract 2
229920002674 hyaluronan Polymers 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
229940124597 therapeutic agent Drugs 0.000 abstract 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
108010028295 histidylhistidine Proteins 0.000 abstract 1
KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 abstract 1
229940099552 hyaluronan Drugs 0.000 abstract 1
229960003160 hyaluronic acid Drugs 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
102000005962 receptors Human genes 0.000 abstract 1
108020003175 receptors Proteins 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70585—CD44
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Cell Biology (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Inorganic Chemistry (AREA)
Vascular Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)
Steroid Compounds (AREA)

NO982935A 1995-12-27 1998-06-24 Hyaluronsyre reseptor bindemiddel og anvendelse derav NO982935L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CA002166155A CA2166155C (en)	1995-12-27	1995-12-27	Agents binding to hyaluronic acid binding domains and the use thereof
PCT/CA1996/000870 WO1997024111A2 (en)	1995-12-27	1996-12-23	Novel hyaluronic acid receptors binding agents and the use thereof

Publications (2)

Publication Number	Publication Date
NO982935D0 NO982935D0 (no)	1998-06-24
NO982935L true NO982935L (no)	1998-08-27

Family

ID=4157242

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO982935A NO982935L (no)	1995-12-27	1998-06-24	Hyaluronsyre reseptor bindemiddel og anvendelse derav

Country Status (15)

Country	Link
EP (1)	EP0874624B1 (de)
JP (1)	JP4210330B2 (de)
KR (1)	KR100476782B1 (de)
AT (1)	ATE255411T1 (de)
AU (1)	AU725478B2 (de)
BR (1)	BR9612355A (de)
CA (1)	CA2166155C (de)
DE (1)	DE69630974T2 (de)
ES (1)	ES2211996T3 (de)
HU (1)	HU226598B1 (de)
IL (1)	IL124828A0 (de)
NO (1)	NO982935L (de)
PL (1)	PL327542A1 (de)
WO (1)	WO1997024111A2 (de)
ZA (1)	ZA9610840B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2237051A1 (en) *	1997-12-19	1999-06-19	Eva A. Turley	Enhanced affinity hyaluronan binding peptides
SE0101854L (sv) *	2001-05-28	2002-11-29	Bioneris Ab	Användning av en förening med en negativt laddad region av grupper för behandling av restenos.
WO2004060404A1 (ja) *	2002-12-27	2004-07-22	Chugai Seiyaku Kabushiki Kaisha	薬物担体
EP1896386B1 (de) *	2005-06-08	2012-09-05	Cangene Corporation	Hyaluronsäurebindende peptide fördern die immunabwehr gegen pathogene bakterien
RU2012157597A (ru)	2010-05-31	2014-07-20	Лондон Хелс Сайенсис Сентр Рисерч Инк.	Rhamm-связывающие пептиды
KR101383941B1 (ko)	2012-03-09	2014-04-10	동아에스티 주식회사	피록시캄 또는 약제학적으로 허용되는 그의 염과 히알루론산 또는 약제학적으로 허용되는 그의 염의 안정한 액상 조성물 및 그 제조방법
US10766927B2 (en)	2012-11-25	2020-09-08	The Regents Of The University Of California	Peptides that stimulate subcutaneous adipogenesis
WO2015184125A1 (en)	2014-05-28	2015-12-03	The Regents Of The University Of California	Peptides, compositions, and methods for stimulating subcutaneous adipogenesis
US10562935B2 (en)	2015-03-20	2020-02-18	London Health Sciences Centre Research Inc.	Stapled peptides and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1340994C (en) *	1989-09-21	2000-05-16	Rudolf Edgar Dr. Falk	Treatment of conditions and disease
CA2122551A1 (en) *	1994-04-29	1995-10-30	Rudolf Edgar Falk	Clearing of atherosclerosis
GB9207949D0 (en) *	1992-04-09	1992-05-27	Univ Manitoba	Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility
AU3159595A (en) *	1994-08-30	1996-03-22	Hyal Pharmaceutical Corporation	Hyaluronic acid and derivatives for modulation of cellular activity

1995
- 1995-12-27 CA CA002166155A patent/CA2166155C/en not_active Expired - Lifetime
1996
- 1996-12-23 DE DE69630974T patent/DE69630974T2/de not_active Expired - Lifetime
- 1996-12-23 EP EP96941564A patent/EP0874624B1/de not_active Expired - Lifetime
- 1996-12-23 KR KR10-1998-0704359A patent/KR100476782B1/ko not_active Expired - Fee Related
- 1996-12-23 AT AT96941564T patent/ATE255411T1/de not_active IP Right Cessation
- 1996-12-23 ZA ZA9610840A patent/ZA9610840B/xx unknown
- 1996-12-23 AU AU10912/97A patent/AU725478B2/en not_active Ceased
- 1996-12-23 IL IL12482896A patent/IL124828A0/xx not_active IP Right Cessation
- 1996-12-23 JP JP52393097A patent/JP4210330B2/ja not_active Expired - Fee Related
- 1996-12-23 WO PCT/CA1996/000870 patent/WO1997024111A2/en not_active Ceased
- 1996-12-23 ES ES96941564T patent/ES2211996T3/es not_active Expired - Lifetime
- 1996-12-23 BR BR9612355-9A patent/BR9612355A/pt not_active Application Discontinuation
- 1996-12-23 PL PL96327542A patent/PL327542A1/xx unknown
- 1996-12-23 HU HU9902059A patent/HU226598B1/hu not_active IP Right Cessation
1998
- 1998-06-24 NO NO982935A patent/NO982935L/no unknown

Also Published As

Publication number	Publication date
WO1997024111A3 (en)	1997-10-02
AU1091297A (en)	1997-07-28
PL327542A1 (en)	1998-12-21
CA2166155A1 (en)	1997-06-28
DE69630974T2 (de)	2004-10-28
HUP9902059A3 (en)	2000-07-28
CA2166155C (en)	2008-02-05
EP0874624A2 (de)	1998-11-04
JP2000506502A (ja)	2000-05-30
ATE255411T1 (de)	2003-12-15
DE69630974D1 (de)	2004-01-15
AU725478B2 (en)	2000-10-12
ES2211996T3 (es)	2004-07-16
ZA9610840B (en)	1997-06-27
BR9612355A (pt)	1999-12-28
JP4210330B2 (ja)	2009-01-14
NO982935D0 (no)	1998-06-24
WO1997024111A2 (en)	1997-07-10
HUP9902059A2 (hu)	2000-04-28
KR100476782B1 (ko)	2005-07-18
KR19990072058A (ko)	1999-09-27
IL124828A0 (en)	1999-01-26
EP0874624B1 (de)	2003-12-03
HU226598B1 (hu)	2009-04-28

Similar Documents

Publication	Publication Date	Title
BR9813373A (pt)	2000-10-03	Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente
UA41989C2 (uk)	2001-10-15	Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
BR0011000A (pt)	2002-02-19	Métodos para prevenir ou tratar uma doença associada com depósitos amilóides de ab no cérebro de um paciente, para avaliar um anticorpo quanto á atividade de remoção de uma entidade biológica fisicamente associada com um antìgeno e para detectara um depósito amilóide em um paciente, composição farmacêutica, e, conjunto de diagnóstico
BR9710689A (pt)	1999-08-17	Processo para tratar diarr-ia aguda e para proporcionar terapia a um mam¡fero tendo diarr-ia e prepara-Æo terap-utica para redu-Æo de sintomas de diarr-ia
WO2007070547A3 (en)	2007-08-16	Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
BR0309890A (pt)	2005-05-10	Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação
NO994275L (no)	1999-10-11	Nikotinsyrepreparater til behandling av hyperlipidemi og tilknyttede fremgangsmaater
BR0213100A (pt)	2004-11-30	Combinações para o tratamento de distúrbios imuniinflamatórios
WO2001043732A3 (en)	2002-03-21	Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies
BR0014166A (pt)	2002-05-14	Método de utilização de inibidores de reabsorção de serotonina seletivo de rápido ataque para tratamento de disfunção sexual
NO982935L (no)	1998-08-27	Hyaluronsyre reseptor bindemiddel og anvendelse derav
BR9813318A (pt)	2000-08-22	Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
BR9500436A (pt)	1995-10-17	Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico
DE60143078D1 (de)	2010-10-28	Pax2 zur behandlung von nierenkrankheiten
ES2157330T3 (es)	2001-08-16	Composicion que comprende aril-alquil-amina meta substituida, usos terapeuticos y diagnosticos.
KR930702995A (ko)	1993-11-29	세포증식 매트릭스 및 그 용도
RU2268052C2 (ru)	2006-01-20	Средство для лечения воспалительных и дегенеративных заболеваний суставов (варианты), способ лечения воспалительных и дегенеративных заболеваний суставов (варианты) и устройство для доставки лекарственного средства к пораженному участку
DK1237562T3 (da)	2005-03-14	Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
MXPA00010254A (es)	2002-08-06	Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
WO1996020950A3 (en)	1996-09-12	Compositions and methods for treating rheumatoid arthritis
CA2529983A1 (en)	2005-02-10	Preoperative treatment of post operative pain
ATE185815T1 (de)	1999-11-15	Verwendung einer therapeutischen zusammensetzungen zur behandlung von verbrennungen
JP2007500133A5 (de)	2007-05-10
GB2079151A (en)	1982-01-20	Medication for relief of intra-articular and intra-muscular discomfort
BR0111900A (pt)	2003-05-13	Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca